Q32 Bio (QTTB) Interest Coverage Ratio (QoQ) (2018 - 2026)
Q32 Bio (QTTB) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Q32 Bio | 215.94 Mn | 165.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.40% |
| Dec 31, 2025 | 3,502.93% |
| Sep 30, 2025 | -457.97% |
| Jun 30, 2025 | 88.89% |
| Mar 31, 2025 | 70.04% |
| Dec 31, 2024 | -12,027.13% |
| Sep 30, 2024 | 79.95% |
| Jun 30, 2024 | -6.86% |
| Mar 31, 2024 | 78.34% |
| Dec 31, 2023 | 59.62% |
| Sep 30, 2023 | 44.65% |
| Jun 30, 2023 | -56.62% |
| Mar 31, 2023 | -9,500.03% |
| Dec 31, 2022 | 73.15% |
| Sep 30, 2022 | -17.98% |
| Jun 30, 2022 | 23.56% |
| Mar 31, 2022 | -285.27% |
| Dec 31, 2021 | 88.36% |
| Sep 30, 2021 | -6.02% |
| Jun 30, 2021 | -2,795.69% |